ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233 | -99.3% | 1,766 | -96.7% | 0.00% | – |
| Q4 2022 | $34,610 | -86.7% | 53,320 | -64.8% | 0.00% | -100.0% |
| Q3 2022 | $260,000 | +45.3% | 151,370 | +5.1% | 0.00% | +100.0% |
| Q2 2022 | $179,000 | -56.8% | 144,025 | -62.1% | 0.00% | -66.7% |
| Q4 2021 | $414,000 | +226.0% | 379,766 | +689.6% | 0.00% | +200.0% |
| Q2 2021 | $127,000 | +28.3% | 48,099 | +22.9% | 0.00% | 0.0% |
| Q4 2020 | $99,000 | +37.5% | 39,141 | +32.7% | 0.00% | -66.7% |
| Q1 2020 | $72,000 | – | 29,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 17,815,708 | $47,033,000 | 2.93% |
| Essex Woodlands Management, Inc. | 2,764,908 | $7,130,000 | 2.60% |
| Belmont Global Advisors, Inc. | 973,000 | $2,569,000 | 2.01% |
| Belmont Global Advisors, Inc. | 135,700 | $358,000 | 0.28% |
| MSD Partners, L.P. | 2,750,000 | $7,260,000 | 0.22% |
| SFMG, LLC | 99,850 | $264,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,090 | $29,000 | 0.03% |
| WESTPORT RESOURCES MANAGEMENT INC | 33,500 | $88,000 | 0.02% |
| SMITH ASSET MANAGEMENT GROUP LP | 236,590 | $625,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 41,150 | $109,000 | 0.02% |